Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hart
Robert J Moots

Showing results (1-10 of 232) with videos related to

Pageof 24
Sort By:
Musculoskeletal Care|August 31, 2010
Manifestations of systemic sclerosis necessitate a holistic approach to patient care: a case reportRobert J Moots
Expert Review of Clinical Immunology|December 18, 2018
Measuring disease activity and response to treatment in rheumatoid arthritisCasandra Buzatu, Robert J Moots
Clinical Medicine (London, England)|February 3, 2017
Behcet's diseaseJagdish R Nair, Robert J Moots
Rheumatology (Oxford, England)|September 4, 2012
The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic reviewRobert J Moots, Barbara Naisbett-Groet
Cytokine|September 29, 2005
Cytokine medicines in clinical practice: current issuesTheresa Barnes, Robert J Moots, John Goodacre
Expert Opinion on Biological Therapy|August 27, 2005
Second International Conference on Cytokine MedicinesTheresa Barnes, John Goodacre, Robert J Moots
Immunotherapy|February 28, 2018
Etanercept for the treatment of rheumatoid arthritisSizheng Zhao, Eduardo Mysler, Robert J Moots
Cytokine|September 29, 2006
Therapeutic targeting of cytokinesTheresa Barnes, John Goodacre, Robert J Moots
Clinical Medicine (London, England)|November 17, 2020
An update on the general management approach to common vasculitidesMooikhin Hng, Sizheng S Zhao, Robert J Moots
Blood|October 19, 2007
The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1Andrew Cross, Robert J Moots, Steven W Edwards
Pageof 24

Showing results (1-10 of 232) with videos related to

Sort By:
Pageof 24
Musculoskeletal Care|August 31, 2010
Manifestations of systemic sclerosis necessitate a holistic approach to patient care: a case reportRobert J Moots
Expert Review of Clinical Immunology|December 18, 2018
Measuring disease activity and response to treatment in rheumatoid arthritisCasandra Buzatu, Robert J Moots
Clinical Medicine (London, England)|February 3, 2017
Behcet's diseaseJagdish R Nair, Robert J Moots
Rheumatology (Oxford, England)|September 4, 2012
The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic reviewRobert J Moots, Barbara Naisbett-Groet
Cytokine|September 29, 2005
Cytokine medicines in clinical practice: current issuesTheresa Barnes, Robert J Moots, John Goodacre
Expert Opinion on Biological Therapy|August 27, 2005
Second International Conference on Cytokine MedicinesTheresa Barnes, John Goodacre, Robert J Moots
Immunotherapy|February 28, 2018
Etanercept for the treatment of rheumatoid arthritisSizheng Zhao, Eduardo Mysler, Robert J Moots
Cytokine|September 29, 2006
Therapeutic targeting of cytokinesTheresa Barnes, John Goodacre, Robert J Moots
Clinical Medicine (London, England)|November 17, 2020
An update on the general management approach to common vasculitidesMooikhin Hng, Sizheng S Zhao, Robert J Moots
Blood|October 19, 2007
The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1Andrew Cross, Robert J Moots, Steven W Edwards
Pageof 24